Cytotoxic T lymphocyte activity in children infected with HIV

Area of Science:

• Immunology
• Virology
• Pediatrics

Background:

• HIV infection in children born to infected mothers presents unique challenges.
• Understanding the immune response, specifically cytotoxic T lymphocyte (CTL) activity, is crucial for managing pediatric HIV.
• Natural history studies provide vital insights into disease progression and immune dynamics.

Purpose of the Study:

• To investigate the development and specificity of CD8 T cell-mediated cytotoxicity against HIV proteins in infected children.
• To correlate CTL activity over time with clinical progression and viral activity.
• To explore the implications of CTL responses for HIV vaccine design.

Main Methods:

• Studied a cohort of children born to HIV-infected mothers, including those infected and uninfected.
• Assessed CTL activity against HIV proteins (Gag, Tat, Pol, Env) using autologous EBV cell lines and peripheral blood mononuclear cells.
• Analyzed clinical data and viral activity in relation to CTL responses.

Main Results:

• Six of nine HIV-infected children exhibited CTL activity against one or more HIV proteins.
• CTL specificity shifted from Tat in younger children to Pol, Gag, or Env in older children.
• Preliminary data showed no clear association between CTL activity and viral load, but children with CTLs tended to be clinically stable.

Conclusions:

• CTL responses against HIV proteins are present in infected children and exhibit age-dependent specificity.
• Further long-term follow-up is required to establish a definitive link between CTL activity and HIV disease progression.
• Understanding CTL specificity is important for designing effective HIV vaccines.